"Designing Growth Strategies is in our DNA"

India Biosafety Cabinets Market Size, Share & Industry Analysis, By Product Type (Class I, Class II, and Class III), By Application (Hazardous Drug Handling, Non-Hazardous Drug Handling, and Other Product Handling), By End User Industry (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institutes, and Others), and Country Forecast, 2026-2034

Last Updated: February 05, 2026 | Format: PDF | Report ID: FBI115374

 

India Biosafety Cabinets Market Size and Future Outlook

Play Audio Listen to Audio Version

The India biosafety cabinets market size was valued at USD 10.8 million in 2025 and is projected to grow from USD 11.4 million in 2026 to USD 17.6 million by 2034, exhibiting a CAGR of 5.6% during the forecast period.

Biosafety cabinets are enclosed workspaces that are used to protect the personnel, environment, and sensitive materials from biohazardous particulates and infectious agents in laboratories. The growing prevalence of chronic conditions, increasing drug development procedures, and rising healthcare expenditure are resulting in a growing adoption of these products in the market.

  • For instance, according to the 2024 statistics published by the World Health Organization (WHO), about 20,414 cases were reported for seasonal influenza in India.

Moreover, improving biosafety standards and the increasing incorporation of technological advancements in these devices by prominent life science companies, such as Thermo Fisher Scientific Inc. and Esco Micro Pte. Ltd., among others, are further contributing to the demand for these products.

India Biosafety Cabinets Market Trends

Technological Advancements to Drive the Demand

There is a growing focus on incorporating technological advancements into these biosafety cabinets, which improves their performance and lifecycle efficiency. The prominent players are emphasizing technologically advanced devices which have  integration of higher-grade HEPA filtration options and smarter airflow control, further minimizing the contamination risk and downtime and enhance energy efficiency.

Moreover, the cabinets are being designed with stronger alarm and decontamination-ready features, which further enable labs to meet periodic certification requirements and internal biosafety expectations. 

  • For instance, in August 2024, Labconco introduced a redesigned Logic Biosafety Cabinet (BSC) with innovative features, aiming to strengthen its product portfolio.

Download Free sample to learn more about this report.

Market Dynamics

Market Drivers

Increasing Prevalence of Chronic Disorders to Fuel Market Growth

The growing prevalence of chronic conditions, such as infectious disorders, is resulting in a rising number of diagnostic procedures among the patient population, subsequently boosting the demand for biosafety cabinets among research professionals.

  • For instance, according to data published by the Global TB Report, it was reported that about 28 lakh people were estimated to have been newly affected with TB in the year 2023 in India.

In addition, the growing focus of governmental organizations on early diagnosis and population-based screening, is further augmenting the adoption rate of these cabinets in the market. Therefore, the factors above, along with the increasing emphasis of key players on research and development activities to introduce innovative products, are expected to fuel the adoption rate of these devices, thereby supporting the India biosafety cabinets market growth.

Other Prominent Drivers

  • Expansion of diagnostic infrastructure and public health surveillance.
  • Stricter biosafety regulations and accreditation requirements.

Market Restraints

High Cost of These Devices to Hamper the Market Growth

There is a growing demand for technologically advanced biosafety cabinets in the market. However, the high cost associated with these advanced devices hampers the adoption rate for these products.

The total ownership cost, including the upfront costs, maintenance costs, and other additional costs, which includes the cost for room airflow discipline, integration of exhaust/ducting, makes it challenging for smaller hospitals and laboratories to adopt these advanced devices. These ongoing costs increases the total ownership cost, which pushes smaller labs toward deferred replacement, purchasing lower cost imports or refurbished equipment, extending product life beyond ideal replacement cycles, thereby hampering the market growth.

  • For instance, according to the 2024 data published by Excedr, Labconco’s BSCs range from USD 6,000 to USD 15,000.

Market Opportunities

Expansion of Healthcare Infrastructure to Create Market Growth Opportunity

There is a rapid expansion in the healthcare sectors in India. The increasing prevalence of chronic conditions, improvement in safety regulations, rising R&D investment in biopharma and vaccines, and rising number of pharmaceutical and biotechnology companies are consequently increasing the adoption of biosafety cabinets in healthcare facilities.

This expansion is also leading to the addition of new labs, which is further driving the capacity augmentation, standardization, workflow upgrades, and introduction of new instruments in the market. Therefore, expansion of the healthcare network is creating a lucrative opportunity among the key players to introduce novel products in the market.

  • According to 2025 statistics published by the India Brand Equity Foundation, there are over 3,000 drug companies in India.

Market Challenges

Regulatory Barriers to Limit the Market Growth

There are growing benefits of technologically advanced biological safety cabinets, resulting in a growing adoption rate for these products in the market. However, the strict regulatory guidelines for these products is one prominent factor hampering the penetration rate of these products in the market. The biosafety cabinets are subjected to various standards, including NABL’s criteria ISO 15189:2022, which drives expectations around controlled facilities/equipment management and other further demands for continuous update of the design of their biosafety cabinets among manufacturers, which adds to additional cost and development time.

  • The ISO/IEC 17025 (testing labs) is used for containment guidance and is commonly applied where labs seek competence accreditation in India.

SEGMENTATION ANALYSIS

By Product Type

Increasing Launches of Class II Cabinets Led to the Class II Segment Dominance

Based on the product type, the market is classified into Class I, Class II, and Class III.

The class II segment held the largest revenue share in 2025. The growth is owing to the prevalence of chronic conditions among patients, resulting in an increasing number of diagnostic tests in the country. This, along with the rising focus of prominent players on launching novel systems for Class II cabinets , is further anticipated to contribute to the segment growth.

  • For instance, in January 2026, Labconco launched the new Prism Class II, Type A2 Biosafety Cabinet with an aim to strengthen its product portfolio.
  • The class III segment is expected to grow at a CAGR of 7.0% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Increasing Number of Microbiology/Virology Laboratories Led to the Dominance of the Other Product Handling Segment

Based on application, the market is segmented into hazardous drug handling, non-hazardous drug handling, and other product handling.

The other product handling segment dominated the India market in 2025. By application, the other product handling segment held the share of 78.6%. The growth is owing to the increasing prevalence of chronic conditions and the expansion of routine microbiology/virology labs, thereby supporting the adoption rate of these devices.

  • For instance, according to the 2024 statistics published by the Department of Health Research, it was reported that 161 VRDLs were established, including 123 VRDLs in medical colleges in India.

The segment of hazardous drug handling is set to flourish with a growth rate of 7.4% across the forecast period.

By End-user Industry

Increasing Number Of diagnostic Laboratories Led To The Segmental Dominance  Of Diagnostic & Testing Laboratories Segment

Based on end user industry, the market is divided into pharmaceutical & biopharmaceutical companies, diagnostic & testing laboratories, academic & research institutes, and others.

The diagnostic & testing laboratories segment dominated the India biosafety cabinets market share in 2025. The increasing prevalence of chronic diseases and growing number of diagnostic laboratories are some of the prominent factors contributing to the growth of the segment. Furthermore, the segment is set to hold a 42.4% share in 2026.

  • According to 2025 statistics published by IAS Score, there are over 300,000 diagnostic labs in India.

In addition, pharmaceutical & biopharmaceutical companiesare projected to grow at a 6.1% during the forecast period.

Competitive Landscape

Key Industry Players

Increasing Number of Product Launches by Key Market Players to Support Their Dominance

A robust and diversified product portfolio, coupled with a strong focus on inorganic growth strategies, is one of the crucial factors supporting the dominance of key companies in the market. Thermo Fisher Scientific Inc. and Kewaunee International Group are the major companies in the market in 2025. Furthermore, the increasing focus of these players on expanding research and development activities to launch novel products is likely to strengthen their brand presence and further support their market shares.

  • In May 2025, Thermo Fisher Scientific Inc., launched the Thermo Scientific 1500 Series Class II, Type A2 biosafety cabinet (BSC), a solution designed to provide protection and operational convenience with an aim to strengthen its product portfolio.

Other key players, including Esco Micro Pte. Ltd., and others are also growing in the market, primarily owing to their growing focus on partnerships with other companies to strengthen their presence in the market.

List of Key India Biosafety Cabinets Companies Profiled

KEY INDUSTRY DEVELOPMENTS

  • January 2025 Biobase Biodusty(Shandong), Co., Ltd., launched a radiation protection biosafety cabinet that combines advanced technology with humanized design, with an aim to strengthen its product portfolio.
  • January 2025 Biobase Bioduty(Shandong), Co., Ltd., organized an event Revealing the Secret of “Biosafety Cabinet”, from January 1st to January 17th, to raise awareness about biosafety cabinets in the market. This helped the company to increase its brand presence.
  • November 2024 – Kewaunee International Group, a player dedicated to laboratory furniture and technical products, acquired NuAire, Inc., with an aim to diversify its product portfolio for biosafety cabinets.
  • October 2024 – Haier Biomedical collaborated with Grosseron and launched a limited-edition pink biosafety cabinet with an aim to raise breast cancer awareness and cater to the increasing prevalence of the condition among patients globally.
  • November 2023 – Esco Micro Pte. Ltd., launched the Labculture Plus G4 Class II Biosafety Cabinet with an aim to strengthen its product portfolio.
  • November 2022 – Haier Biomedical launched Mini and Dual Exhaust Filter Model HR700-IIA2 and HR900-IIA2-D biosafety cabinets with an aim to strengthen its product portfolio.
  • April 2021 – Tecniplast Group acquired BioAir Spa with the aim of widening its portfolio for biosafety cabinets and other equipment globally.

REPORT COVERAGE

The report provides a detailed India biosafety cabinets market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, application, and end user industry. Besides this, the India report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 5.6% from 2026-2034

Unit

Value (USD Million)

Segmentation

By Product Type, Application, End User  Industry, and Region

By Product Type

·         Class I

·         Class II

·         Class III

By Application

·         Hazardous Drug Handling

·         Non-Hazardous Drug Handling

·         Other Product Handling

By End User Industry

·         Pharmaceutical & Biopharmaceutical Companies

·         Diagnostic & Testing Laboratories

·         Academic & Research Institutes

·         Others



Frequently Asked Questions

Fortune Business Insights says that the India market size was USD 10.8 million in 2025 and is projected to reach USD 17.6 million by 2034.

Growing at a CAGR of 5.6%, the market will exhibit steady growth over the forecast period.

By product type, the class II segment is the leading segment in this market.

The introduction of novel biological safety cabinets is one of the major factors driving the market growth.

Thermo Fisher Scientific Inc., and Kewaunee International Group are the major players in the Indian market.

The growing prevalence of chronic disorders, the increasing number of diagnostic procedures, among others, are some of the prominent factors expected to boost the adoption rate of these products in the country.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 161
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann